Publication:
Hair repigmentation associated with the use of brentuximab

Thumbnail Image

Open/View Files

5683745.pdf (600.34 KB)

Date

2017

Authors

Published Version

10.1016/j.jdcr.2017.09.027

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Penzi, Lauren R., Athena Manatis-Lornell, Arturo Saavedra, David Fisher, and Maryanne M. Senna. 2017. “Hair repigmentation associated with the use of brentuximab.” JAAD Case Reports 3 (6): 563-565. doi:10.1016/j.jdcr.2017.09.027. http://dx.doi.org/10.1016/j.jdcr.2017.09.027.

Research Data

Abstract

Description

Other Available Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683745/pdf/

Keywords

aging, antibody-drug conjugate, brentuximab, graying, hair follicle, hair repigmentation, melanocyte, cGVHD, chronic graft versus host disease, IL, interleukin, TNF, tumor necrosis factor

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:34493295

Collections

FAS Scholarly Articles
HMS Scholarly Articles

Endorsement

Review

Supplemented By

Referenced By

Related Stories